Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Radiotherapy

8 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Supportive Care

    Neuro-Oncology

    NRGNEUCC001

    07/14/2016

    A Randomized Phase III Trial of Memantine and Whole-Brain Radiotherapy with or without Hippocampal Avoidance in Patients with Brain Metastases

    Treatment

    Sarcoma

    COGARST1431

    08/18/2016

    A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating with Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864, IND# 122782) in Patients with Intermediate Risk (IR) Rhabdomyosarcoma (RMS)

    Treatment

    Neuro-Oncology

    NRGNEUR0631

    07/15/2016

    Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine Metastasis

    Treatment

    Breast

    NRGBREB-51

    04/13/2016

    A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative Axillary Nodes After Neoadjuvant Chemotherapy

    Treatment

    Prostate

    ECOGUROR0924

    03/10/2016

    Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial

    Treatment

    Bladder

    ECOGUROGU001

    02/29/2016

    Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder Cancer

    Treatment

    Breast

    VICCBRE1298

    04/19/2013

    A Safety and Efficacy Study of Intra-Operative Radiation Therapy (IORT) Using the Xoft? Axxent? eBx System at the Time of Breast Conservation Surgery for Early Stage Breast Cancer

    Treatment

    Breast

    CTSUBRENB-43-M

    04/26/2012

    A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy


    Print this page for your doctor